Anxiety treatment in the U.S. is on the verge of rapid innovation after a long period of time without new medication options. Both researchers and clinicians highlight that a variety of new clinical trials and therapies will soon be available for the treatment of generalized anxiety disorder and related conditions.
An exciting development concerning anxiety treatment is a compound, MM120, derived from LSD, which has recently undergone successful Phase 2 trials for generalized anxiety disorder. In a protocol involving a single dose, many participants experienced effects lasting for weeks and hence, it was suggested that a new form of anxiety treatment might not necessarily be based on daily medication. Phase 3 clinical studies have been lined up, which have increased expectations of the U.S. being able to welcome the first anxiety treatment drug class after almost two decades.
Psychedelic, assisted therapies, for example, psilocybin, based methods, are also being considered as possible anxiety treatment options, mainly for individuals whose anxiety symptoms are resultant from trauma or terminal illness. Preliminary studies imply that these therapies, along with proper preparation and post, therapy sessions, are capable of bringing about profound changes in the way emotions are processed and how meaning is derived.
Simultaneously, digital tools such as app, based CBT programs and AI, guided coaching are trying to personalize and make accessible the anxiety treatment. These applications assist individuals in identifying their triggers, trying out coping mechanisms, and communicating with clinicians, thus facilitating anxiety treatment even without traditional office visits.
Professionals warn that despite the development of new models to treat anxiety, there are still unresolved issues concerning the regulation, pricing, equity, and training of such models. Furthermore, there is a necessity to guarantee that innovative therapies are available to those communities which, historically, have been left out of the most advanced forms of care. However, for many people who have had a hard time dealing with only partial relief or the side effects of existing medications, the present pipeline of research turns this into a moment of a little hope for the future of anxiety treatment.
Source: Compass – How New Research Could Transform Anxiety Treatment
Leave a Comment